Drug intelligence / Profile preview

tumor necrosis factor-α

Development stage
Phase 3
Lead developer
TNF Pharmaceuticals
Modality
Gene Therapies, Cytokines & Interferons → Recombinant Proteins and Enzymes
01

Overview

Tumor necrosis factor-α (TNF-α) is a pro-inflammatory cytokine produced primarily by activated macrophages and other immune cells. It plays a central role in inflammation and immune regulation. In the context of disease treatment, most clinical applications target inhibition of TNF-α rather than administration of the cytokine itself. However, in experimental settings such as cancer therapy (e.g., intratumoral injection for pancreatic cancer), recombinant or adenovector-delivered TNF-α has been investigated for its ability to induce tumor cell death and enhance immune responses[6][8]. The mechanism involves binding to specific receptors on target cells, leading to activation of signaling pathways that can result in apoptosis or necroptosis.

Brand names
AurasolMesoGold
Other names
Tumor Necrosis Factor-alphaCachectinTNFalpha
02

Targets

TNFRSF1A (Tumor necrosis factor receptor superfamily member 1A)TNFR2 (Tumor necrosis factor receptor superfamily member 1B)

Beyond the preview

Go deeper on tumor necrosis factor-α.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tumor necrosis factor-α.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call